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Glial type specific regulation of CNS angiogenesis
by HIFα-activated different signaling pathways
Sheng Zhang 1,2,5, Bokyung Kim 1,2,5, Xiaoqing Zhu1,4, Xuehong Gui1, Yan Wang1,2, Zhaohui Lan1,2,
Preeti Prabhu1, Kenneth Fond1, Aijun Wang 1,3 & Fuzheng Guo 1,2✉
The mechanisms by which oligodendroglia modulate CNS angiogenesis remain elusive.
Previous in vitro data suggest that oligodendroglia regulate CNS endothelial cell proliferation
and blood vessel formation through hypoxia inducible factor alpha (HIFα)-activated Wnt (but
not VEGF) signaling. Using in vivo genetic models, we show that HIFα in oligodendroglia is
necessary and sufficient for angiogenesis independent of CNS regions. At the molecular level,
HIFα stabilization in oligodendroglia does not perturb Wnt signaling but rather activates
VEGF. At the functional level, genetically blocking oligodendroglia-derived VEGF but not Wnt
significantly decreases oligodendroglial HIFα-regulated CNS angiogenesis. Blocking astroglia-
derived Wnt signaling reduces astroglial HIFα-regulated CNS angiogenesis. Together, our
in vivo data demonstrate that oligodendroglial HIFα regulates CNS angiogenesis through
Wnt-independent and VEGF-dependent signaling. These findings suggest an alternative
mechanistic understanding of CNS angiogenesis by postnatal glial cells and unveil a glial cell
type-dependent HIFα-Wnt axis in regulating CNS vessel formation.
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The vasculature of the central nervous system (CNS), whichis developed exclusively through angiogenesis, plays acrucial role in providing neural cells with nutrients and
oxygen. CNS angiogenesis, the growth of new blood vessels from
pre-existing ones, starts during embryonic development and
matures during postnatal development in human and rodent
brains, for example, by the age of one month in rodents1. Dys-
regulated CNS angiogenesis negatively impacts postnatal brain
development and functional recovery from brain injuries2–4. The
current study aimed to dissect the molecular regulation of post-
natal CNS angiogenesis using in vivo genetic animal models.
The developing CNS parenchyma is exposed to physiological
hypoxia with local oxygen concentration ranging from 0.5 to 7%5.
Hypoxia-inducible factor α (HIFα) is a critical regulator that
adapts neural cells to hypoxic conditions. The transcription factor
HIFα, including HIF1α and HIF2α, is subjected to constant
degradation. Von Hippel-Lindau (VHL), a negative regulator of
HIFα’s transcriptional activity, plays an essential role in HIFα
degradation. Under low oxygen or upon VHL disruption, HIF1α
and HIF2α degradation is impaired and subsequently translocate
into the nuclei where they regulate downstream target genes
through forming transcriptional active complexes with the con-
stitutive HIF1β6,7. Previous data suggest that HIFα function in
neural precursor cells is required for embryonic brain vascular
development8. Recent data including those from our own
laboratory show that HIFα function in oligodendroglial lineage
cells may play a pivotal role in regulating postnatal angiogenesis
in the brain white matter9 and in the spinal cord10. However, the
molecular mechanisms underlying oligodendroglial HIFα-
regulated angiogenesis are still controversial and remain incom-
pletely defined.
The current concept stated that oligodendroglial HIFα pro-
motes CNS angiogenesis through activating signaling pathway of
Wnt but not vascular endothelial growth factor (VEGF)9. How-
ever, this “Wnt-dependent” view was supported only by in vitro
studies and pharmacological manipulations9, in which “patholo-
gical” activation of Wnt signaling, poor cell-type selectivity and/
or off-target effects of small compounds cannot be excluded. In
this study, we present in vivo evidence supporting an alternative
view in our mechanistic understanding of oligodendroglial HIFα-
regulated CNS angiogenesis. Our in vivo genetic knockout data
reveal that oligodendroglial HIFα regulates endothelial cell pro-
liferation and angiogenesis in a VEGF-dependent but Wnt-
independent manner and this regulation is independent of CNS
regions during postnatal development. This data also demon-
strate that postnatal astroglia regulate CNS angiogenesis at least
in part through HIFα-activated Wnt signaling, unveiling a glial
cell type-specific HIFα-Wnt connection in the CNS.
Results
Oligodendroglial HIFα regulates CNS angiogenesis. Endothelial
cell (EC) proliferation is an essential step of angiogenesis and the
blood vessel density is an end-point reflection of angiogenesis.
Therefore, we used EC proliferation and vessel density as in vivo
readouts of angiogenesis9. To quantify blood vessel density, we
used the basement membrane marker Laminin to label blood
vessels and employed a semi-automated approach to calculate the
percentage of Laminin-occupying area among total assessed area
(Supplementary Fig. 1). To determine whether oligodendroglial
HIFα is required for angiogenesis throughout the postnatal CNS,
Cre-LoxP approach was used to genetically ablate or stabilize
HIFα and EC proliferation and vessel density were analyzed in
the brain and the spinal cord.
We used Cnp-Cre line11 to generate Cnp-Cre:Hif1αfl/fl (HIF1α
conditional knockout, cKO), Cnp-Cre: Hif2αfl/fl (HIF2α cKO),
and Cnp-Cre: Hif1αfl/fl:Hif2αfl/fl (HIF1α/HIF2α or HIFα double
cKO) mutants (Supplementary Fig. 2). Mice carrying Cnp-Cre
transgene alone did not display any developmental abnormalities
compared with non-Cre animals as previously reported11 and
supported by our assessment of CNS angiogenesis at postnatal 10
and motor function at postnatal one month (Supplementary
Fig. 3). HIF1α cKO or HIF2α cKO did not influence blood vessel
density, indicating a compensatory effect of oligodendroglial
HIF1α and HIF2α on angiogenesis. In contrast, HIF1α/HIF2α
double cKO (refer to as HIFα cKO hereafter) significantly
impaired CNS angiogenesis evidenced by reduced blood vessel
density (Fig. 1a–c) and diminished EC proliferation not only in
the cerebral cortex but also in the spinal cord at postnatal 14
(Fig. 1d–g), suggesting that oligodendroglial HIFα is necessary for
CNS angiogenesis.
The HIFα protein is constantly translated but subjected to
rapid turnover via proteasome-mediated degradation, a process in
which Von Hippel-Lindau product (VHL) is essential for HIFα
degradation. Therefore, we employed Cnp-Cre:Vhlfl/fl transgenic
mice to genetically ablate VHL and stabilize HIFα function in
oligodendroglial lineage cells (Supplementary Fig. 4). We found
that the density of blood vessels and the proliferation of ECs were
significantly increased in the cerebral cortex and spinal cord of
Cnp-Cre:Vhlfl/fl mice compared with those of non-Cre control
mice at different time points in the early postnatal CNS
(Fig. 1h–j). Stabilizing HIFα in oligodendroglial lineage cells did
not have a major effect on the integrity of the blood-brain (spinal
cord) barrier in the adult Cnp-Cre:Vhlfl/fl mice (Supplementary
Fig. 5).
Previous studies have reported that Cnp-Cre primarily targets
oligodendroglial lineage cells and also a subpopulation of early
neural progenitor cells12,13. To corroborate the conclusion
derived from Cnp-Cre transgenic mice, we assessed CNS
angiogenesis in a different animal strain Sox10-Cre:Vhlfl/fl in
which Sox10-Cre mediated HIFα stabilization in the earlier stages
of oligodendrocyte development in the CNS. Consistently, CNS
angiogenesis was significantly increased in Sox10-Cre:Vhlfl/fl
mutants, as assessed by elevated blood vessel density (Fig. 1k),
EC-specific Pecam1 mRNA expression (Fig. 1l), and EC densities
(Fig. 1m). Taken together, our loss (gain)-of-function results
suggest that oligodendroglial HIFα is necessary and sufficient for
angiogenesis and that the angiogenic regulation by oligoden-
droglial HIFα is independent of CNS regions.
Oligodendroglial HIFα does not regulate Wnt signaling. To
determine whether HIFα in oligodendroglial lineage cells reg-
ulates Wnt/β-catenin signaling, we quantified the Wnt/β-catenin
target gene Axin2, Naked1, and Notum, which are reliable read-
outs for the signaling activation10. We found no significant
changes in the mRNA levels of those genes in HIFα-stabilized
spinal cord and forebrain of Cnp-Cre:Vhlfl/fl mutants at different
time points (Fig. 2a) compared with those of non-Cre controls.
Consistently, western blot assay showed that the active form of β-
catenin (dephosphorylated on Ser37 or Thr41) and Axin2 did not
change (Fig. 2b), indicating that stabilizing oligodendroglial HIFα
does not perturb the activity of Wnt/β-catenin signaling in the
CNS. Furthermore, we found no significant change in the mRNA
level of Wnt7a in the CNS of Cnp-Cre:Vhlfl/fl mice compared with
non-Cre controls (Fig. 2c). We crossed Wnt reporter transgenic
mice BAT-lacZ14 with Cnp-Cre:Vhlfl/fl mutants and found no
difference in lacZ mRNA level in the spinal cord of BAT-lacZ/
Cnp-Cre:Vhlfl/fl mice compared with age-matched BAT-lacZ mice
(Fig. 2d).
We further assessed the activity of Wnt/β-catenin signaling in a
different animal strain of Sox10-Cre:Vhlfl/fl mice. Consistent with
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Fig. 1 CNS region-independent regulation of angiogenesis by oligodendroglial HIFα. a Representative images of blood vessels labeled by the basement
membrane marker Laminin in the spinal cord of Cnp-Cre:Hif1αfl/fl:Hif2αfl/fl and non-Cre littermate controls at postnatal day 14 (P14). Scale bars= 100 μm.
b Percentage of Laminin+ area among total assessed area. Two-tailed Student’s t test with Welch’s correction, t(4.618)= 4.767, n= 5 each group. c RT-
qPCR assay of Pecam1 mRNA (a.k.a. CD31), a marker of endothelial cells (ECs), in the P14 spinal cord. Two-tailed Student’s t test, t(8)= 2.526, n= 5 each
group. d–f Representative images of immunohistochemical staining of ERG (a nuclear marker of ECs), isolectin B4 (IB4, labeling blood vessel basement
membrane), and EdU (labeling actively dividing cells) and densities of marker positive cells (# per mm2) in Cnp-Cre, Hif1αfl/fl, Hif2αfl/fl and littermate
control mice at P14. Two hours EdU pulse labeling. Two-tailed Student’s t test, ERG+, t(6)= 5.200 cortex, t(6)= 6.358 spinal cord; ERG+EdU+, t(6)= 4.496
cortex, t(6)= 6.365 spinal cord. n= 4 each group. g Percentage of ERG+ ECs that are EdU+. Two-tailed Student’s t test, t(6)= 4.089 cortex, t(6)=
3.181 spinal cord. n= 4 each group. h Representative images and quantification of Laminin in the spinal cord of P8 Cnp-Cre, Vhlfl/fl, and non-Cre control
mice. Two-tailed Student’s t test, t(5)= 8.831. n= 4 Ctrl, 3 VHL cKO. i Densities (per mm2) of ERG+ ECs and ERG+EdU+ proliferating ECs in the P8 spinal
cord. Two-tailed Student’s t test, t(5)= 11.10 ERG+, t(5)= 9.981 ERG+EdU+. n= 4 Ctrl, 3 VHL cKO. j RT-qPCR of Pecam1 mRNA in P14 spinal cord. Two-
tailed Student’s t test with Welch’s correction, t(3.081)= 5.941. n= 6 Ctrl, 4 VHL cKO. k Representative images and quantification of Laminin in P5 Sox10-
Cre, Vhlfl/fl and non-Cre controls. Two-tailed Student’s t test, t(6)= 3.625 spinal cord, t(6)= 3.428 cortex. n= 5 Ctrl, 3 VHL cKO. l RT-qPCR of Pecam1
mRNA in P5 spinal cord. Two-tailed Student’s t test with Welch’s correction, t(4.309)= 3.257. n= 8 Ctrl, 5 VHL cKO. m Densities (per mm2) of ERG+ ECs
at P5. Two-tailed Student’s t test, t(6)= 6.964 cortex, t(6)= 5.324 spinal cord. n= 5 Ctrl, 3 VHL cKO. Scale bar: a, k 100 μm; d, h 50 μm. Data are shown as
mean ± s.d. Source data of b, c, e, m are provided as a Source Data file.
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Cnp-Cre:Vhlfl/fl mice, HIFα was stabilized in the CNS of Sox10-
Cre:Vhlfl/fl mutants, as shown by the elevated expression of HIFα
target gene Hk2 (Fig. 2e). However, Wnt/β-catenin signaling was
not perturbed, as evidenced by similar activity of Wnt/β-catenin
signaling assessed at the mRNA (Fig. 2f) and protein (Supple-
mentary Fig. 6) levels. The unperturbed activity of Wnt/β-catenin
signaling was further corroborated by evidence from a time-
conditional Pdgfrα-CreERT2:Vhlfl/fl strain in which Pdgfrα-
CreERT2 elicited a greater than 85% of recombination efficiency
and specificity in early postnatal oligodendrocyte progenitor cells
(OPCs) (Supplementary Fig. 7). Tamoxifen-induced VHL abla-
tion in OPCs resulted in HIFα stabilization and elevated
angiogenesis, as demonstrated by significant increase in the
expression of HIFα target gene Hk2 and EC-specific Pecam1
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(Fig. 2g) and the density of cerebral blood vessels (Fig. 2h).
However, the mRNA expression of Wnt target genes Ainx2 and
Sp5 (Fig. 2i) and the protein levels of active β-catenin and Naked1
(Supplementary Fig. 8) were indistinguishable between Pdgfrα-
CreERT2:Vhlfl/fl mutants and non-Cre controls, indicating that
Wnt/β-catenin signaling activity was not altered by oligoden-
droglial HIFα stabilization.
Previous study reported an autocrine activation of Wnt/β-
catenin signaling in OPCs by HIFα stabilization9. To assess the
autocrine activity of Wnt/β-catenin signaling, we treated purified
primary OPCs with HIFα stabilizer DMOG9 in the presence or
absence of HIFα signaling blocker Chetomin15 (Supplementary
Fig. 9a). Our results showed that pharmacological stabilizing
HIFα activated HIFα signaling target genes (Supplementary
Fig. 9b) but did not activate Wnt/β-catenin target genes nor
Wnt7a and Wnt7b (Supplementary Fig. 9c) in primary OPCs
isolated from neonatal brain. We also quantified the activity of
Wnt/β-catenin signaling in primary OPCs which were isolated
from neonatal Sox10-Cre:Vhlfl/fl brain. Consistent with the in vivo
data (Fig. 2e), HIFα target genes were significantly increased in
primary VHL-deficient OPCs (Fig. 2j). However, neither Wnt/β-
catenin target genes Axin2 and Naked1 nor Wnt7a were
increased in primary VHL-deficient OPCs (Fig. 2k), suggesting
that stabilizing oligodendroglial HIFα does not perturb Wnt/β-
catenin signaling in primary OPCs.
To determine whether HIFα deletion affects Wnt/β-catenin
signaling, we analyzed Wnt/β-catenin activity in the early
postnatal CNS of Cnp-Cre:HIFα cKO and Pdgfrα-CreERT2:HIFα
cKO mutants. Consistent with HIFα-stabilized mutants (Fig. 2),
we found no evidence of Wnt/β-catenin signaling perturbation in
both strains of HIFα cKO mutants (Supplementary Fig. 10).
Collectively, our in vivo and in vitro data demonstrate that Wnt/
β-catenin signaling is unlikely a downstream target of oligoden-
droglial HIFα as previously reported9 and suggest that oligoden-
droglial HIFα may regulate CNS angiogenesis independent of
Wnt/β-catenin signaling.
OPC autocrine Wnt signaling is dispensable for angiogenesis.
WLS is an essential factor of Wnt secretion from Wnt-producing
cells and its deficiency blocks Wnt ligands from activating the
downstream pathways in Wnt-receiving cells16–19. To determine
whether WLS deficiency affects Wnt secretion from oligoden-
droglial lineage cells, we knocked down WLS in primary Wnt7a-
expressing OPCs and assessed Wnt secretion and autocrine Wnt/
β-catenin activity (Fig. 3a, b). Because Wnt7a has been shown
as one of the major Wnt ligand genes expressed in OPCs at
the mRNA level9,20, we overexpressed Wnt7a in primary OPCs.
Our enzyme-linked immunosorbent assay (ELISA) of the culture
medium showed that WLS knockdown significantly reduced
Wnt7a concentration secreted from Wnt7a-expressing OPCs
(Fig. 3c). Autocrine Wnt/β-catenin signaling was activated in
Wnt7a-expressing OPCs, as evidenced by the increased expres-
sion of Wnt target genes Axin2 and Sp5 (Fig. 3d), but this acti-
vation was blocked in WLS-deficient OPCs (Fig. 3d). Our data
suggest that WLS is required for Wnt secretion from OPCs.
To define the putative in vivo role of Wnt signaling in HIFα-
regulated CNS angiogenesis, we generated VHL/WLS double
mutant hybrids to block Wnt secretion from HIFα-stabilized
oligodendroglial lineage cells (Fig. 4a). Because constitutive
Sox10-Cre:Vhlfl/fl pups died at very early postnatal ages, we used
an inducible Cre line Sox10-CreERT2 to stabilize HIFα and
disrupt WLS (Fig. 4b, c) in Sox10+ oligodendroglial lineage cells
(OPCs and differentiated oligodendroglia). Our fate-mapping
data showed that Sox10-CreERT2 elicited ~60% of recombination
efficiency and greater than 90% of oligodendroglial specificity in
Sox10+ oligodendroglial lineage cells in the early postnatal CNS
(Supplementary Fig. 11). We confirmed that HIFα’s function was
indeed stabilized in the spinal cord of Sox10-CreERT2:Vhlfl/fl
(HIFα-stabilized mice) and Sox10-CreERT2:Vhlfl/fl:Wlsfl/fl(HIFα-
stabilized/WLS-disrupted mice), as evidenced by the elevated
expression of HIFα target gene Hk2 (Fig. 4d) and Ldha (Fig. 4e)
in comparison with non-Cre controls. Our analysis demonstrated
that blocking Wnt secretion by disrupting WLS did not alter
HIFα stabilization-elicited CNS angiogenesis in HIFα-stabilized/
WLS-disrupted mice compared with HIFα-stabilized mice, which
was supported by unchanged levels of endothelial Pecam1 mRNA
expression (Fig. 4f) and unchanged densities of blood vessels
(Fig. 4g–j), ERG+ ECs (Fig. 4k), and ERG+EdU+ dividing ECs
(Fig. 4l) in the spinal cord and cerebral cortex of HIFα-stabilized/
WLS-disrupted mice compared with those of HIFα-stabilized
mice. These data suggest that oligodendroglial lineage-derived
Wnt signaling plays a minor role in HIFα-regulated angiogenesis
in the early postnatal CNS.
Next, we used a different Cre transgenic line Pdgfrα-CreERT2 to
stabilize HIFα specifically in OPCs. OPC-specific HIFα stabiliza-
tion enhanced blood vessel density (Fig. 5a–d) and increased the
number of ERG+ ECs (Fig. 5e, f) in the spinal cord and cerebral
cortex of Pdgfrα-CreERT2:Vhlfl/fl animals compared with those in
non-Cre controls. However, blocking Wnt secretion from OPCs
by disrupting WLS did not affect blood vessel formation and
endothelial cell density in the CNS of HIFα stabilized/WLS-
disrupted mice compared with HIFα stabilized mice (Pdgfrα-
CreERT2:Vhlfl/fl:Wlsfl/fl versus Pdgfrα-CreERT2:Vhlfl/fl) (Fig. 5c–f).
The data from two independent Cre transgenic lines collectively
Fig. 2 Oligodendroglial HIFα does not activate Wnt/β-catenin signaling. a RT-qPCR assay of mRNA levels of HIFα target gene Hk2 and Wnt/β-catenin
target genes Axin2, Naked1, and Notum. Two-tailed Student’s t test, t(6)= 3.936 Hk2, t(6)= 1.275 Axin2 at P2; t(5)= 0.1307 Axin2 at P8; t(8) = 0.4906 Axin2,
t(8)= 0.8386 Naked1, t(8)= 1.821 Notum at P14 spinal cord; t(8)= 1.736 Axin2, t(8)= 0.5617 Naked1 at P14 forebrain. n= 6 Ctrl, 4 VHL cKO. bWestern blot
assay of total β-catenin, active β-catenin, and Axin2. Two-tailed Student’s t test, t(4)= 1.247 β-catenin, t(4)= 0.5869 active β-catenin, t(4)= 0.614 Axin2.
n= 3 each group. c RT-qPCR of Wnt7a mRNA. Two-tailed Student’s t test, t(6)= 0.960 P2 spinal cord, t(6)= 0.3724 P2 forebrain, t(8)= 1.736 P8 spinal
cord. n= 4 each group at P2, n= 6 Ctrl, 4 VHL cKO at P8. d RT-qPCR of lacZ mRNA in Wnt/β-catenin reporter mice (BAT-lacZ) that had been crossed
onto Cnp-Cre, Vhlfl/fl and non-Cre control backgrounds. Two-tailed Student’s t test, t(8)= 0.6072. n= 6 BAT-lacZ, 4 Cnp-Cre,Vhlfl/fl,BAT-lacZ. e, f RT-qPCR
assay of mRNA level of Hk2, Axin2, Naked1, Wnt7a, and Wnt7b in the spinal cord of Sox10-Cre:Vhlfl/fl and non-Cre controls at P5. Two-tailed Student’s t
test, t(11)= 7.011 Hk2, t(11) = 0.7422 Axin2, Welch’s corrected t(4.345)= 0.392 Naked1, t(11)= 0.3216 Wnt7a, Welch’s corrected t(4.709)= 0.4827 Wnt7b.
n= 8 Ctrl, 5 VHL cKO. g RT-qPCR of HIFα target gene Hk2 and EC marker Pecam1 in P14 spinal cord. Two-tailed Student’s t test, t(4)= 4.158 Hk2, t(4)=
3.231 Pecam1. n= 3 each group. h Percent of laminin-occupying area among total area in the cerebral cortex at P14. Two-tailed Student’s t test, t(4)= 3.724.
n= 3 each group. i Expression of Wnt/β-catenin target gene Axin2 and Sp5 in the spinal cord at P14 quantified by RT-qPCR. Two-tailed Student’s t test, t(4)
= 0.5021 Axin2, t(4)= 2.006 Sp5. n= 3 each group. j, k RT-qPCR assay of mRNA levels of HIFα target genes and Wnt signaling genes in primary OPCs
isolated from the neonatal brain of Sox10-Cre, Vhlfl/fl and non-Cre control mice. Two-tailed Student’s t test, Welch’s corrected t(6.282)= 6.065 Hk2, Welch’s
corrected t(7.898)= 12.92 Ldha, Welch’s corrected t(6.199)= 4.009 Glut1, t(11)= 4.654 Pkm2, t(11)= 0.7772 Axin2, t(11)= 0.4936 Naked1, t(11)= 1.394 Wnt7a.
n= 6 Ctrl, 7 VHL cKO. Data are shown as mean ± s.d. Source data of a–k are provided as a Source Data file.
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suggest that oligodendroglia-derived Wnt signaling is dispensable
for HIFα-regulated CNS angiogenesis in vivo.
Oligodendroglial HIFα activates VEGFA. A previous study
reported that VEGFA was unperturbed by oligodendroglial HIFα
stabilization9. We revisited the potential connection between
HIFα and VEGFA in oligodendrocytes both in vivo and in vitro.
HIF1α cKO (or HIF2α cKO) alone did not alter Vegfa mRNA
level in the CNS of Cnp-Cre:Hif1αfl/fl (or Cnp-Cre:Hif2αfl/fl)
mutants compared with non-Cre controls (data not shown),
indicating a redundancy of oligodendroglial HIF1α and HIF2α in
regulating VEGFA. HIFα double cKO (i.e., Cnp-Cre:Hif1αfl/fl:
Hif2αfl/fl) decreased Vegfa mRNA expression in the spinal cord
(Fig. 6a) and reduced the secretion of VEGFA from primary brain
OPCs into the culture medium (Fig. 6b). Conversely, genetic
HIFα stabilization by VHL deletion increased Vegfa mRNA
expression in the spinal cord of Cnp-Cre:Vhlfl/fl animals (Fig. 6c,
d1–d4). Double fluorescent in situ hybridization confirmed that
Vegfa mRNA was upregulated in Plp mRNA+ oligodendroglial
lineage cells in vivo (Fig. 6e1–e2). Moreover, time-conditional
and stage-specific VHL cKO demonstrated that genetic HIFα
stabilization activated VEGFA not only in PDGFRα+ OPCs
(Pdgfrα-CreERT2:Vhlfl/fl strain) (Fig. 6f) but also in PLP+ oligo-
dendroglia (Plp-CreERT2:Vhlfl/fl strain) (Fig. 6g). Pharmacological
DMOG treatment increased Vegfa mRNA expression and HIFα
signaling blocker Chetomin prevented DMOG-induced Vegfa
activation in primary OPCs purified from neonatal murine brains
(Fig. 6h). Furthermore, Vegfa mRNA was elevated by greater than
3-fold in primary OPCs purified from neonatal Sox10-Cre:Vhlfl/fl
mice compared with those from non-Cre littermate controls
(Fig. 6i). All these data suggest that VEGFA is regulated by HIFα
in oligodendroglial lineage cells.
Oligodendroglial HIFα regulates angiogenesis through
VEGFA. The regulation of VEGFA by oligodendroglial HIFα led
us to hypothesize that VEGFA may be a crucial downstream
molecule that couples oligodendroglial HIFα and CNS endothelial
cell proliferation and vessel formation. To test this hypothesis, we
generated Pdgfrα-CreERT2:Vhlfl/fl:Vegfafl/fl (HIFα-stabilized/
VEGFA-disrupted), Pdgfrα-CreERT2:Vhlfl/fl (HIFα-stabilized),
and non-Cre control mice (Fig. 7a, b). The mRNA level of EC-
specific marker PECAM1 was significantly attenuated in the
spinal cord of PdgfrαCreERT2:Vhlfl/fl: Vegfafl/fl mice compared
with that of Pdgfrα-CreERT2:Vhlfl/fl mice (Fig. 7c). The densities
of blood vessels (Fig. 7d, e), ERG+ total ECs (Fig. 7f), and ERG
+BrdU+ proliferating ECs (Fig. 7g) were all significantly reduced
in the spinal cord and cerebral cortex of Pdgfrα-CreERT2:Vhlfl/fl:
Vegfafl/fl mice compared with those of Pdgfrα-CreERT2:Vhlfl/fl
mice. These data demonstrate that VEGFA disruption attenuates
oligodendroglial HIFα-regulated CNS angiogenesis, thus provid-
ing unambiguous in vivo data arguing for an essential role of
VEGFA in coupling oligodendroglial HIFα function and CNS
angiogenesis.
Astroglial HIFα regulates CNS angiogenesis via Wnt signaling.
Astroglial maturation is also temporally and functionally coupled
with postnatal CNS angiogenesis. We assess the connection of
astroglial HIFα and Wnt/β-catenin activation in the CNS. We
first used the mouse Gfap promoter-driven constitutive Cre, i.e.
mGfap-Cre to genetically stabilize HIFα in astroglia. The effi-
ciency of mGfap-Cre-mediated recombination among astroglial
lineage cells, quantified by Cre-mediated EYFP reporter, was low
(~35%) in the CNS in the early postnatal CNS by P10 (Supple-
mentary Fig. 12a–c) and progressively increased during postnatal
CNS development (Supplementary Fig. 12d–f). Our fate-mapping
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data showed that EYFP reporter, which is an indicator of mGfap-
Cre activity, was expressed in GFAP+ or S100β+ astrocytes, but
not in Sox10+ oligodendroglial lineage cells, NeuN+ neurons
(Fig. 8a), or ERG+ ECs (data not shown) in the spinal cord and
the cerebral cortex of adult mGfap-Cre:Rosa26-EYFP mice at P60,
confirming that mGfap-Cre primarily targets astroglial lineage
cells in those CNS regions.
We observed a significant increase in the density of Laminin+
blood vessels (Fig. 8b, c) and in the mRNA expression of EC-specific
PECAM1 (Fig. 8d) throughout the CNS of mGfap-Cre:Vhlfl/fl
mutants compared with non-Cre control mice by P30 when Cre-
mediated recombination efficiency was greater than 80% (Fig. 8a,
Supplementary Fig. 12). Double immunohistochemistry showed that
blood-borne macromolecule IgG was confined to Laminin+ blood
vessels in mGfap-Cre:Vhlfl/fl mice, a similar pattern to that in age-
matched non-Cre controls (Fig. 8e, arrowheads), indicating that the
function of the blood-brain (spinal cord) barrier does not appear
compromised although the vessel density is elevated.
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Unexpectedly, we found that stabilizing HIFα in astroglial
lineage cells (Fig. 8f) remarkably activated Wnt/β-catenin
signaling in the CNS of mGfap-Cre:Vhlfl/fl mice, as shown by
significant elevation in the expression of Wnt/β-catenin signaling
target genes Axin2 and Notum in spinal cord and brain (Fig. 8g).
Histological (Fig. 8h) and Western blot (cf Fig. 9a, b) assay
demonstrated that the active form of β-catenin (dephosphory-
lated on Ser37 or Thr41) was significantly increased in mGfap-
Cre:Vhlfl/fl mice. Double immunohistochemistry confirmed the
presence of elevated active β-catenin in PECAM1+ ECs (Fig. 8i,
arrowheads). Collectively, our data suggest that stabilizing HIFα
in astroglial lineage cells increases CNS angiogenesis and activates
Wnt/β-catenin signaling in ECs.
Wnt/β-catenin signaling activation in ECs by astroglial HIFα
stabilization led us to hypothesize that astroglia-derived Wnt
signaling may instead play a major role in HIFα-regulated CNS
angiogenesis. To test this hypothesis, we generated mGfap-Cre:
Vhlfl/fl:Wlsfl/fl mice to stabilize HIFα’s function and simulta-
neously disrupting Wnt secretion from HIFα-stabilized astro-
glia. Our data showed that Wnt signaling activity was
significantly reduced in the spinal cord of mGfap-Cre:Vhlfl/fl:
Wlsfl/fl mice compared with that of mGfap-Cre:Vhlfl/fl mice
(Fig. 9a, b), thus verifying the efficacy of blocking astroglia-
derived Wnt signaling in vivo by WLS deletion. Intriguingly,
disrupting astroglia-derived Wnt signaling significantly reduced
the densities of blood vessels (Fig. 9c–e) and ERG+ ECs
(Fig. 9f–h) in the CNS of mGfap-Cre:Vhlfl/fl:Wlsfl/fl double
mutant mice compared with mGfap-Cre:Vhlfl/fl mice, indicating
that astroglia-derived Wnt signaling is a downstream mediator
of astroglial HIFα-regulated CNS angiogenesis.
Our results indicated that the constitutive mGfap-Cre elicited a
poor recombination efficiency in early postnatal astrocytes
(Supplementary Fig. 12). To determine whether early postnatal
astrocytes regulate CNS angiogenesis through HIFα-activated
Wnt signaling, we generated Aldh1l1-CreERT2:Vhlfl/fl:Wlsfl/fl
mutants. Our data demonstrated a greater than 90% of
recombination efficiency and 95% of astroglial specificity in the
spinal cord and cerebral cortex of Aldh1l1-CreERT2:Rosa26-EYFP
at P8 when tamoxifen was injected at P1, P2 and P3
(Supplementary Fig. 13). Consistent with the data derived from
mGfap-Cre:Vhlfl/fl:Wlsfl/fl strain, we found that the densities of
blood vessels and ECs were significantly increased in Aldh1l1-
CreERT2:Vhlfl/fl mutants compared with those in non-Cre
controls and that simultaneous WLS ablation significantly
reduced the densities of blood vessels and ECs in the cortex
and spinal cord of Aldh1l1-CreERT2:Vhlfl/fl:Wlsfl/fl mutants
compared with those of Aldh1l1-CreERT2:Vhlfl/fl animals at early
postnatal age of P8 (Fig. 10). These data provide a strong genetic
proof that HIFα-activated Wnt signaling is a major downstream
pathway by which astroglia regulate angiogenesis during post-
natal CNS development.
Discussion
The maturation of glial cells including oligodendroglia and
astroglia in the developing human and murine brain is temporally
and functionally coupled with the maturation of the CNS vascular
network21. The regulation of CNS angiogenesis by glial cells is
critical for postnatal CNS development and investigating the
molecular underpinnings of CNS angiogenesis has clinical
implications in neural repair after CNS damage in which hypoxia
is commonly present4,21,22. In this study, we employed a battery
of genetic mutant mice and presented several significant findings:
(1) oligodendroglial HIFα is necessary and sufficient for postnatal
CNS angiogenesis and this regulation occurs in a manner inde-
pendent of CNS regions; (2) in sharp contrast to the previous
report9, HIFα stabilization in oligodendroglial lineage cells does
not perturb Wnt/β-catenin signaling, but remarkably activates
VEGF, and genetically blocking oligodendroglia-derived VEGF
but not Wnt reduces oligodendroglial HIFα-regulated CNS
angiogenesis; (3) Wnt signaling is a downstream pathway by
which astroglial HIFα regulates CNS angiogenesis. Our findings
represent an alternative view in our mechanistic understanding of
oligodendroglial HIFα-regulated angiogenesis from a Wnt-
dependent/VEGF-independent view9 to a VEGF-dependent/
Wnt-independent one, and also unveil a glial cell type-dependent
HIFα-Wnt axis (oligodendroglial vs astroglia) in regulating CNS
angiogenesis (Supplementary Fig. 14).
Previous data suggested that the regulation of Wnt/β-catenin
signaling (activation or repression) by HIFα is cell type and/or
context-dependent10,23–27. It is important to determine whether
HIFα in CNS glial cells differentially regulates Wnt/β-catenin
signaling in vivo. A recent study reported that oligodendroglial
HIFα could activate Wnt/β-catenin signaling not only in oligo-
dendroglial lineage cells but also in endothelial cells through
HIFα-mediated Wnt7a/7b expression9. However, the in vivo and
in vitro data presented in this study do not support this assertion.
Here, we employed five different strains of oligodendroglial Cre
(two constitutive Cre and three inducible Cre) to genetically
stabilize HIFα and found no evidence of Wnt/β-catenin activation
or Wnt7a/7b upregulation in the brain and the spinal cord and in
primary OPCs. The failure to detect Wnt/β-catenin activation is
unlikely due to the inefficiency of HIFα stabilization because the
Fig. 4 Blocking Wnt secretion from oligodendroglial lineage cells does not affect HIFα-regulated CNS angiogenesis. a Schematic diagram depicting
putative regulation between HIFα-Wnt axis in glio-vascular units. b Primer design (left) and PCR detection (right) of Wls gene deletion. Primer pair of F2/R
is for detecting Wls floxed allele (556bp). After Cre-mediated deletion, primer pair F1/R generates a 410 bp product from the genome of Sox10-CreERT2,
Wlsfl/fl mice. c RT-qPCR assay of exon 1-coding Wls mRNA. One-way ANOVA followed by Tukey’s multiple comparisons, *P < 0.05, ns, not significant.
F(2,7)= 10.39, P= 0.008. n= 4 Ctrl, 3 VHL cKO, 3 VHL/WLS cKO. d–f, RT-qPCR assay of Hk2, Ldha, and Pecam1 mRNA. One-way ANOVA followed by
Tukey’s multiple comparisons, *P < 0.05, **P < 0.01, *** P < 0.001, ns, not significant. F(2,9)= 21.73, P= 0.0004 Hk2, F(2,9)= 14.14, P= 0.0017 Ldha,
F(2,9)= 10.39, P= 0.0046 Pecam1. n= 6 Ctrl, 3 VHL cKO, 3 VHL/WLS cKO. g, h Representative confocal images of Laminin-positive blood vessels in the
spinal cord and the percent of Laminin-positive BV area among total assessed area. One-way ANOVA followed by Tukey’s multiple comparisons, *P < 0.05,
ns, not significant. F(2,11)= 8.8, P= 0.0052. n= 8 Ctrl, 3 VHL cKO, 3 VHL/WLS cKO. Scale bars= 100 µm. i, j Representative confocal images of Laminin-
positive blood vessels in the forebrain cerebral cortex and the percent of Laminin-positive BV area among total assessed area. One-way ANOVA followed
by Tukey’s multiple comparisons, **P < 0.01, ns, not significant. F(2,12)= 16.47, P= 0.0004. n= 9 Ctrl, 3 VHL cKO, 3 VHL/WLS cKO. Scale bars= 100 µm.
k Densities (#/mm2) of ERG+ endothelial cells. One-way ANOVA followed by Tukey’s multiple comparisons, *P < 0.05, **P < 0.01, ns, not significant.
F(2,9)= 16.89, P= 0.0009 spinal cord; Welch’s ANOVA followed by unpaired t test with Welch’s correction, W(2,5.346)= 65.98, P= 0.0002 cortex. n= 4
Ctrl, 4 VHL cKO, 4 VHL/WLS cKO. l Densities (#/mm2) of ERG+/EdU+ proliferating endothelial cells (2 h EdU pulse labeling prior to tissue harvesting at
P8). One-way ANOVA followed by Tukey’s multiple comparisons, *P < 0.05, **P < 0.01, ns, not significant. F(2,9)= 10.63, P= 0.0043 spinal cord, F(2,9)=
18.43, P= 0.0007 cortex. n= 4 Ctrl, 4 VHL cKO, 4 VHL/WLS cKO. Data are shown as mean ± s.d. Source data of c–f, h, j, k, l are provided as a Source
Data file.
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canonical HIFα target genes, for example, those which are
involved in glycolysis, are consistently and significantly upregu-
lated in our transgenic animals and in primary OPCs, thus ver-
ifying the efficacy of HIFα stabilization. In sharp contrast, we
found that Wnt/β-catenin signaling activity is significantly
upregulated in the CNS of astroglial HIFα-stabilized mice, sug-
gesting that our experimental approach is effective in quantifying
the changes of Wnt/β-catenin activity and that the regulation of
Wnt/β-catenin signaling by HIFα is glial cell type-dependent in
the CNS.
Inspired by glial cell type (oligodendroglia vs astroglia)-
dependent activation of Wnt/β-catenin signaling, we proposed
a working model in which HIFα-activated Wnt signaling reg-
ulates endothelial cell proliferation and vessel formation in a
cell type-dependent manner (Supplementary Fig. 14). To avoid
the intrinsic caveats of pharmacological compounds and
in vitro culture systems, we employed in vivo genetic models of
VHL/WLS double cKO to stabilize HIFα and simultaneously
disrupt the secretion of Wnt ligands. Indeed, our data
demonstrate that WLS-deficiency decreases Wnt secretion and
Wnt7a-induced autocrine Wnt/β-catenin signaling in primary
OPCs and that disrupting WLS in astroglia reduces the activity
of astroglial HIFα-regulated Wnt/β-catenin signaling in the
CNS. Based on VHL/WLS double cKO systems, we provide
strong genetic evidence that HIFα-regulated Wnt signaling
from astroglia but not oligodendroglia plays a crucial role in
regulating postnatal CNS angiogenesis. Our findings argue
against a major role oligodendroglia-derived/HIFα-activated
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Wnt/β-catenin signaling in angiogenesis in the developing
murine CNS as previously reported9.
There are 19 Wnt ligands in rodents, which can be grossly
classified into canonical and non-canonical sub-types depend-
ing on the necessity of β-catenin for the signaling activation10.
WLS ablation blocks the secretion of all Wnt members
from Wnt-producing cells16–19,28. In our genetic models, we
demonstrate that ablation of WLS remarkably reduces astroglial
HIFα-mediated canonical Wnt/β-catenin signaling. However,
we cannot exclude the possibility that astroglia-derived non-
canonical Wnt signaling is also altered in our genetic manip-
ulation which may be potentially involved in CNS angiogenic
regulation29. Moreover, it remains unclear which Wnt ligand(s)
plays a major role in coupling astroglial HIFα with CNS
angiogenesis. Our preliminary data do not support a major role
of Wnt7a/7b, because neither Wnt7a nor Wnt7b expression was
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t(6)= 2.590. n= 4 Ctrl, 4 HIFα cKO. b ELISA measurement of VEGFA concentration in the culture medium of primary OPCs isolated from neonatal forebrain
of indicated genotypes. Two-tailed Student’s t test, t(8)= 4.208. n= 4 Ctrl, 6 HIFα cKO. c RT-qPCR assay of Vegfa mRNA in the spinal cord. Two-tailed
Student’s t test, t(6)= 4.127 at P2; Welch’s correction t(3.139)= 4.299 at P14. n= 4 each group. d1–d4 Vegfa mRNA in situ hybridization in the spinal cord
of P8 transgenic mice. Arrowheads point to Vegfa mRNA+ cells. Note that Vegfa mRNA signals were higher in the Cnp-Cre, Vhlfl/fl spinal cord (d2) than
those in the non-Cre controls (d4). e1–e2 Vegfa and Plp dual fluorescent mRNA in situ hybridization in P8 spinal cord. Boxed areas were shown at higher
magnification in single color channels. Note that Vegfa mRNA signals are higher in Plp+ oligodendrocytes in Cnp-Cre, Vhlfl/fl mutants than those in non-Cre
controls. Scale bars: 10 µm. f RT-qPCR assay of Hk2 and Vegfa mRNA in the spinal cord of P14 Pdgfrα-CreERT2, Vhlfl/fl and non-Cre littermate controls that
had been treated with tamoxifen (TM) at P6 and P7. Two-tailed Student’s t test, t(4)= 2.822 Hk2, t(4) = 4.770 Vegfa. n= 3 each group. g RT-qPCR assay of
the mRNA levels of HIFα target genes Ldha, and Mct1 and Vegfa in the spinal cord of P14 Plp-CreERT2, Vhlfl/fl and non-Cre littermate controls that had been
treated with tamoxifen at P6 and P7. Two-tailed Student’s t test, t(7)= 2.487 Mct1, t(7)= 7.194 Vegfa; Two-tailed Student’s t test with Welch’s correction,
t(5.079) = 3.116 Ldha. h RT-qPCR assay of Vegfa mRNA in primary OPCs treated with HIFα stabilizer MOG and inhibitor Chetomin (cf Supplementary Fig. 9).
Welch’s ANOVA followed by unpaired t test with Welch’s correction, **P < 0.01.W(2,5.270)= 79.93, P= 0.0012. n= 4 each group. i RT-qPCR assay of Vegfa
mRNA in primary OPCs isolated from neonatal brains of Sox10-Cre, Vhlfl/fl mutants and littermate controls. Two-tailed Student’s t test, Welch’s-corrected
t(7.008)= 12.38. n= 3 Ctrl, 7 VHL cKO. Data are shown as mean ± s.d. Source data of a–c, f–i are provided as a Source Data file.
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activated in oligodendroglial and astroglial HIFα-stabilized
CNS. Future studies are needed to pinpoint which Wnt ligand
(s) are the downstream mediator(s) of astroglial HIFα-regulated
CNS angiogenesis.
VEGF (i.e. VEGFA) is a well-established angiogenic and neu-
rotrophic factor in the CNS4,30–35. VEGFA regulates angiogenesis
in the developing and adult CNS through its membrane-bound
receptors VEGFR-1(Flt1) and VEGFR-2 (Kdr)30. In the early
postnatal CNS, VEGFR-1 and 2 are highly expressed in the vas-
cular ECs. However, the ligand VEGFA is barely detectable in the
vascular ECs but highly expressed in the parenchymal neural cells
including oligodendroglial lineage cells20,36–38. The previous
study suggested that the HIFα-VEGF connection did not occur in
the CNS oligodendroglia9 although this connection was demon-
strated in the retina39. In this study, we found that oligoden-
droglial HIFα cKO reduces VEGFA whereas oligodendroglial
HIFα stabilization increases VEGFA expression, indicating that
HIFα transcriptionally regulates VEGFA in oligodendroglial
lineage cells. Further corroborating these findings, purified pri-
mary OPCs respond to HIFα signaling stabilizer (DMOG) and
blocker (Chetomin) by activating and inactivating VEGFA,
respectively. Our results are consistent with previous data showing
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NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-15656-4 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:2027 | https://doi.org/10.1038/s41467-020-15656-4 |www.nature.com/naturecommunications 11
that VEGFA is a direct transcriptional target of HIFα40–42.
By leveraging our unique in vivo genetic models of VHL/VEGFA
double cKO, we unequivocally prove that VEGFA is an essential
downstream molecule that couples oligodendroglial HIFα function
and vascular angiogenesis in the CNS, which is different from
Yuen et al.9, who reported that VEGFA was unchanged in
the CNS of oligodendroglial HIFα-stabilized mutants. The dis-
crepancy may presumably reflect the intrinsic differences of
in vitro pharmacological interventions and in vivo genetic
manipulations.
It has been suggested that Wnt signaling regulates VEGF,
or vice versa, to control angiogenesis43–45. It is possible that
Wnt/β-catenin signaling is required for, or synergistically reg-
ulates, HIFα-activated VEGFA expression. Our data do not
support this possibility. First, stabilizing oligodendroglial HIFα
activates VEGFA but not Wnt/β-catenin signaling. Second,
VEGF expression is indistinguishable in the CNS of oligoden-
droglial VHL/WLS double cKO mutants from that of oligo-
dendroglial VHL single cKO mutants (data not shown),
indicating that oligodendroglial-derived Wnt signaling plays a
minor role in VEGFA expression. Third, Wnt/β-catenin activity
is comparable in the CNS of oligodendroglial VHL/VEGFA
double cKO mutants and VHL single cKO mutants, implying
that oligodendroglia-derived VEGFA has no regulatory role in
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Wnt/β-catenin activity. Together, our results do not support a
major interplay between oligodendroglial HIFα-activated VEGFA
and Wnt/β-catenin signaling in modulating CNS angiogenesis.
Previous studies including those from our own
laboratory10,12,46–49 have shown that dysregulated Wnt/β-catenin
activity invariably inhibits oligodendrocyte differentiation and
myelination. Given the normal level of Wnt/β-catenin activity in
the CNS of oligodendroglial HIFα-stabilized mutants, our study
will spark renewed interests in studying Wnt-independent
mechanisms underlying the impairment of oligodendroglial dif-
ferentiation and myelination in HIFα-stabilized mutants as pre-
viously reported9. Interestingly, HIFα is stabilized and enriched in
oligodendroglia in the active demyelinating lesions and normal-
appearing white matter (NAWM) of multiple sclerosis patient
brains50–53. We show that HIFα stabilization in oligodendrocytes
remarkably activates the angiogenic and neurotrophic factor
VEGF in the CNS. The genetic models generated in our study also
provide a powerful tool in determining the role of HIFα stabili-
zation in OPCs and oligodendrocytes in the pathophysiology of
demyelination and remyelination in multiple sclerosis and other
neurological disorders in which hypoxia-like tissue injury occurs.
Methods
Animals. A total of 14 transgenic strains were used in this study. Cnp-Cre mice
(RRID: MGI_3051754)11, Sox10-Cre (RRID: IMSR_JAX:025807), Sox10-CreERT2
(RRID:IMSR_JAX: 027651), Pdgfrα-CreERT2 (RRID: IMSR_JAX:018280),
Aldh1l1-CreERT2 (RRID: IMSR_JAX:029655), Plp-CreERT2 (RRID:
IMSR_JAX:005975), mGfap-Cre (RRID: IMSR_JAX:024098), Hif1α-floxed (RRID:
IMSR_JAX:007561), Hif2α-floxed (RRID: IMSR_JAX:008407), Vhl-floxed (RRID:
IMSR_JAX:012933), Wls-floxed (RRID: IMSR_JAX:012888), Vegfa-floxed
(MGI:1931048)54, Bat-lacZ (RRID: IMSR_JAX:005317), Rosa26-EYFP (RRID:
IMSR_JAX:006148). Animals were housed at 12h light/dark cycle with free access
to food and drink, and both males and females were used in this study. The single
transgenic mice were crossed to generate double or triple transgenic mice indicated
in the study. All Cre transgene was maintained as heterozygous. All transgenic
mice were maintained on a C57BL/6 background. Animal protocols were approved
by Institutional Animal Care and Use Committee at the University of
California, Davis.
Primers used for genotyping Hif1α-floxed, Hif2α-floxed, and Vhl-floxed and for
detecting Cre-mediated DNA deletion (as in Figs. 1a and 2a, b) were derived from
previous study55 and listed here. Hif1α-F1: 5′-TTGGGGATGAAAACATCTGC-3′,
Hif1α-F2: 5′-GCAGTTAAGAGCACTAGTTG-3′, Hif1α-R: 5′-GGAGCTATCTC
TCTAGACC-3′), Hif2α-F1:5′-CAGGCAGTATGCCTGGCTAATTCCAGTT-3′,
Hif2α-F2: 5′-CTTCTTCCATCATCTGGGATCTGGGACT-3′, Hif2α-R: 5′-GCT
AACACTGTACTGTCTGAAAGAGTAGC-3′, Vhl-F1: 5′-CTGGTACCCACG
AAACTGTC-3′, Vhl-F2: 5′-CTAGGCACCGAGCTTAGAGGTTTGCG-3′ Vhl-R:
5′-CTGACTTCCACTGATGCTTGTCACAG-3′. Primers used for genotyping
Wls-floxed for detecting Cre-mediated DNA deletion (as in Fig. 7b) were derived
from previous study18 and listed here. Wls-F1: 5′-CTTCCCTGCTTCTTTAAGC
GTC-3′, Wls-F2: 5′-AGGCTTCGAACGTAACTGACC-3′, Wls-R: 5′-CTCAGAAC
TCCCTTCTTGAAGC-3′
Tamoxifen and BrdU (or EdU) treatment. Tamoxifen (TM) (T5648, Sigma) was
dissolved in mixture of ethanol and sunflower oil (1:9 by volume) at a con-
centration of 30 mg/ml14. Mice were administrated intraperitoneally (i.p.) with
tamoxifen at dose of 200 μg/g body weight at time points indicated in each figure.
BrdU (B5002, Sigma) or EdU (A10044, Thermo Fisher Scientific) was freshly
dissolved in 0.9% sterile saline at a concentration of 10 mg/ml. BrdU or EdU was i.
p. injected to animals at a dose of 100 μg/g body weight at time-points indicated in
the figures. Tamoxifen was administered to both the controls and the inducible
floxed mice in all experiments involving inducible Cre-LoxP approach.
Primary OPC culture. Primary mixed glial culture (MG) was prepared from the
forebrains of neonatal pups between ages P0 and P2. The isolated cortical tissues
were dissociated by papain dissociation kit (#LK003176, Worthington) supple-
mented with DNase I (250 U/ml; #D5025, Sigma) and D-(+)-glucose (0.36%;
#0188 AMRESCO) in 33 °C/10% CO2 for 90 min. Next, the tissues were transferred
in PDS Kit-Inhibitor solution (#LK003182, Worthington). Tissue chunks were
triturated, and then collect the cell suspension supernatant. After centrifugation,
cells were plated on poly-D-lysine (PDL, #A003-E, Millipore)-coated 10 cm dishes
(#130182, Thermo Scientific) in high-glucose DMEM medium (#1196092, Thermo
Fisher) with 10% heat-inactivated fetal bovine serum (#12306-C, Sigma) and
penicillin/streptomycin (P/S, #15140122, Thermo Fisher). After 24 h, attached cells
were washed with HBSS (#24020117, Thermo Fisher) to remove serum, and
maintained with serum-free growth medium (GM), a 3:7 mixture (v/v) of B104
neuroblastoma-conditioned medium, 10 ng/ml Biotin (#B4639, Sigma), and N1
medium (high-glucose DMEM supplemented with 5 μg/ml insulin (#I6634, Sigma),
50 μg/ml apo-transferrin (#T2036, Sigma), 100 μM Putrescine (#P5780, Sigma), 30
nM Sodium selenite (#S5261, Sigma), 20 nM Progesterone (#P0130, Sigma). We
performed immunopanning 96 h after GM maintenance. Before immunopanning,
cells were resuspended in panning solution (0.1% BSA in N1 medium). The cells
were panned once with the anti-Thy1.2 antibody (#105302, Biolegend) for negative
immunopanning and then panned once with the anti-NG2 antibody (#AB5320,
Millipore) for positive immunopanning. OPCs were cultured on PDL-coated plates
with complete GM. The complete GM consisted of GM with 5 ng/ml FGF (#450-
33, Peprotech), 4 ng/ml PDGF-AA (#315-17, Peprotech), 50 µM Forskolin
(#6652995, Peprotech,) and glutamax (#35050, Thermo Fisher). To induce differ-
entiation, the medium was switched to differentiation medium (DM), which
consists of 12.5 μg/ml insulin, 100 μM Putrescine, 24 nM Sodium selenite, 10 nM
Progesterone, 10 ng/ml Biotin, 50 μg/ml Transferrin (#T8158, Sigma), 30 ng/ml
3,3′,5-Triiodo-L-thyronine (#T5516, Sigma), 40 ng/ml L-Thyroxine (#T0397,
Sigma-Aldrich), glutamax and P/S in F12/high-glucose DMEM, 1:1 in medium
(#11330032, Thermo Fisher Scientific).
HIFα signaling stabilization and inhibition in vitro. Purified brain primary OPCs
were pre-incubated with 100 nM Chetomin or DMSO control for 2 h, and then
switched to the fresh culture medium with 1 mM Dimethyloxalylglycine (DMOG,
D3695, Sigma) in the presence of 100 nM Chetomin (C9623, Sigma) or DMSO
(D8418, Sigma) control for 7 h before RNA preparation.
VEGFA ELISA assay. Cell culture medium of primary OPCs from Non-Cre
control and Cnp-Cre, Hif1αfl/fl, Hif2αfl/fl were collected for VEGF measurement.
Endogenous VEGF concentrations were determined using a mouse-specific VEGF
Quantikine ELISA kit (t#MMV00, R&D System) according to the manufacture’s
instruction.
Transfection in primary OPCs and ELISA assay. Primary OPCs was transfected
with Wls-ShRNA (TRCN 0000 234932, Mission ShRNA bacterial Glycerol stock
Fig. 8 Astroglial HIFα stabilization promotes CNS angiogenesis and enhances Wnt signaling activity. a Fate-mapping study showing that mGfap-Cre-
mediated EYFP was expressed in GFAP+ astrocytes but not in Sox10+ oligodendroglial lineage cells or NeuN+ neurons in the spinal cord at P60. WM,
white matter, GM, gray matter, Ctx, cortex. EYFP was identified as S100β+ astrocytes in the cerebral Ctx. Scale bars= 20 μm. b Representative images of
Laminin immunostaining in mGfap-Cre, Vhlfl/fl mutants and non-Cre control mice at P30. Scale bars= 100 μm. c Percentage of Laminin-occupying area
among total area at P30. Two-tailed Student’s t test, Welch’s corrected t(4)= 11.92 spinal crd, t(7)= 10.12 cerebral cortex. n= 4 Ctrl, 5 VHL cKO. d RT-
qPCR assay of endothelial Pecam1 at P30. Two-tailed Student’s t test, Welch’s corrected t(4.046)= 8.564 spinal cord, Welch’s corrected t(4.490)= 6.706
forebrain. n= 5 each group. e immunostaining showing that endogenous mouse IgG is restricted to Laminin+ blood vessels (arrowheads) in the early adult
spinal cord of mGfap-Cre,Vhlfl/fl mutant and control mice at P47. Scale bars= 10 μm. f RT-qPCR assay of the mRNA levels of HIFα target gene Glut1, Hk2
and Ldha in P30 spinal cord. Two-tailed Student’s t test with Welch’s correction, t(4.099)= 7.947 Glut1, t(4.243)= 9.636 Hk2, t(4.085)= 9.025 Ldha. n= 4
Ctrl, 5 VHL cKO. g RT-qPCR assay of the mRNA levels of Wnt/β-catenin target genes Axin2 and Notum at P30. Two-tailed Student’s t test, Welch’s
corrected t(4.760)= 7.296 spinal cord Axin2, t(8)= 2.902 forebrain Axin2, Welch’s corrected t(4.149)= 4.850 spinal cord Notum, t(8)= 4.994 forebrain
Notum. n= 5 each group. h Immunostaining of active β-catenin in the spinal cord of mGfap-Cre, Vhlfl/fl mutants and non-Cre control mice at P30. Scale
bars= 10 μm. i Double immunostaining of active β-catenin and PECAM1 in the spinal cord of mGfap-Cre, Vhlfl/fl mutants at P30. Arrowheads point to
double-positive cells. Blue is DAPI nuclear staining. Scale bars= 10 μm. Data are shown as mean ± s.d. Source data of c, d, f, g are provided as a Source
Data file.
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NM_026582) and ShRNA scramble control (Mission TRC2 PlkO.5-PURO Non-
Mammalian shRNA control Plasmid), Wnt7a plasmid pLCN-Wnt7a-HA
(Addgene, #18036) and empty pLCN-exp (Addgene, #64865) at the time points
indicated in Fig. 3a. The transfection was done by using FuGENE6 Transfection
reagent (Promega, #E2691, lot#000371257). The Wnt7a in OPCs cell medium was
measured by using mouse Wnt7a ELISA kit (Cusabio, #CSB-EL026141MO,
Lot#G19147708) according to the manual of the kit.
Immunohistochemistry and blood vessel quantification. Study mice were per-
fused with ice-cold phosphate buffered saline (PBS, pH = 7.0, Catalog #BP399-20,
Fisher Chemical), and then post-fix in fresh 4% paraformaldehyde (PFA, Catalog
#1570-S, Electron Microscopy Science,PA) at room temperature(RT) for 2 h. The
CNS tissue was washed in ice-cold PBS for three times, 15 min each time. The
samples were cryoprotected with 30% sucrose in PBS (Sucrose, Catalog #S5-3,
Fisher Chemical) for 20 h followed by sectioning. Sixteen microns thick sections
were serially collected and stored in −80 °C. Immunohistochemistry was con-
ducted as below: slices were air dry in RT for at least 1 h, and then were blocked
with 10% Donkey (Dky) serum for 1 h at RT. Tissue was incubated with primary
antibody overnight at 4 °C. Slices were washed for 15 min in PBST (PBS with 0.1%
Tween-20) for three times, then incubated with fluorescence conjugated secondary
antibody (1:500; Alexa-fluorescence from Jackson ImmunoResearch) for 1.5 h at
RT. Slices were washed 15 min in PBST (PBS with 0.1% Tween-20) for three times.
The immunostaining was done before incubating with DAPI nuclear staining for
10 min56,57. The information of primary antibodies used for immunohistochem-
istry in the study were listed in Supplementary Table 1. For BrdU immunostaining,
sections were pretreated with fresh-made 2N HCl (#320331, Sigma) followed by the
above immunostaining procedures.
To quantify blood vessel density, we used projected confocal images at 40x
magnification (Nikon C1) followed by NIH ImageJ automated processing. At least
three sections from each mouse were used for ImageJ quantification. Ten-micron-
thick optical sections from confocal z-stack images were projected into a flattened
image. The parameter setting of z-stack confocal imaging is below: total optical
thickness, 10 μm, step size, 0.5 μm, total number optical slices, 21. The volume-
rendered confocal images were subsequently imported to NIH ImageJ 1.46r for
quantifying Laminin-positive blood vessel density using a customer-defined Macro
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program. The total area and Laminin-occupying area were derived and from
ImageJ and exported to Microsoft Excel for calculating the percent of Laminin-
occupying area among assessed total CNS area.
mRNA In Situ hybridization (ISH). We employed the PCR and in vitro tran-
scription to prepare cRNA probes targeting Vegfa and Plp58. Targeted sequences of
Vegfa and Plp were generated by PCR. The primers used were: Vegfa-Forward:
GGATATGTTTGACTGCTGTGGA; Vegfa-Reverse: AGGGAAGATGAGGAA
GGGTAAG; Plp-Forward: GGGGATGCCTGAGAAGGT; Plp-Reverse: TGTGA
TGCTTTCTGCCCA. We added the T7 (GCGTAATACGACTCACTATAGGG)
and SP6 (GCGATTTAGGTGACACTATAG) promoter sequences to the 5’ of the
forward and reverse primers, respective. The SP6 and T7 promoter sequences are
recognized by the SP6 and T7 RNA polymerase, respectively, in the subsequence
in vitro transcription. PCR products of Vegfa and Plp amplification were used as
DNA templates to transcribe into Vegfa and Plp cRNA probes in vitro using SP6
RNA polymerase. T7 RNA polymerase-mediated transcription of RNA was used as
negative control. DIG-UTP or FITC-UTP was used to generate DIG- or FITC-
labeled cRNA probes.
Single or dual mRNA ISH was done using our previous protocols58. Frozen
sections of 14 μm thickness were used. The concentration of cRNA probe we used
was 100 ng/100 μl hybridization buffer. Hybridization was conducted at 65 °C for
18–20 h. After hybridization, sections were treated with 10 μg/ml RNase A to
eliminate nonspecific cRNA binding. For single mRNA ISH with DIG-labeled
cRNA probes, DIG was recognized by alkaline phosphatase (AP)-conjugated anti-
DIG (#11093274910, Sigma) antibody and DIG signals were visualized by the NBT/
BCIP (#72091, Sigma) method. For dual fluorescence mRNA ISH (Vegfa and Plp),
FITC-labeled Plp cRNA probe and DIG-labeled Vegfa cRNA probe were applied to
frozen sections simultaneously during the hybridization step. The FITC signals
were visualized by tyramide signal amplification (TSA) fluorescence system
(#NEL747A, Perkin Elmer) according to the manufacturer’s instructions using
horseradish peroxidase (HRP)-IgG Fraction Monoclonal Mouse Anti-Fluorescein
(#200-032-037, Jackson ImmunoResearch). DIG signals were visualized by a HNPP
fluorescent kit (#11758888001, Sigma) according to the manufacturer’s instructions
using AP-conjugated anti-DIG Fab2 antibody (#11093274910, Sigma).
Western blot. Protein concentration was assessed by BCA protein assay kit
(#23225, Thermo Fisher Scientific). Twenty microgram protein lysates were
separated on AnykD Mini-PROTEAN TGX precast gels (#4569035, BIO-RAD) or
10% Mini-PROTEAN TGX precast gels (#4561035, BIO-RAD). The proteins were
transferred onto 0.2 μm nitrocellulose membrane (#1704158, BIO-RAD) by Trans-
blot Turbo Transfer system (#1704150, BIO-RAD). The membranes were blocked
with 5% BSA (#9998, Cell signaling) for 1h at room temperature and were incu-
bated overnight with primary antibodies (Supplementary Table 2) at 4 °C. The
membranes were washed 3 times with 10 mm Tris-HCl (pH 7.5) containing 150
mM NaCl and 0.1% Tween-20 (TBST) and were incubated with horseradish
peroxidase-conjugated goat anti-rabbit (31460, RRID: AB_228341, Thermo Fisher
Scientific) or anti-mouse (31430, RRID: AB_228307, Thermo Fisher Scientific) for
1h at room temperature. After incubation, the membranes were washed three times
with TBST. Specific binding was detected using Western Lightening Plus ECL
(NEL103001EA, Perkin Elmer). NIH Image J 1.44p was used to quantify protein
expression levels by analyzing the scanned grey-scale films.
RNA preparation and RT-qPCR. Total RNA was extracted by using Qiagen
RNeasy for lipid tissues (74804, Qiagen) with additional on-column DNase I
digestion to remove genomic DNA contamination. The quality and quantity of
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Fig. 10 Conditionally blocking Wnt secretion from neonatal astrocytes reduces HIFα-regulated CNS angiogenesis in the early postnatal CNS. a
Representative confocal images of Laminin and IB4 in the cerebral cortex of each group of mice at P8 that had been treated with tamoxifen at P1, P2, and
P3. b Percentage of Laminin-occupying area among the total area at P8. Cortex, one-way ANOVA followed by Tukey’s multiple comparisons, *P < 0.05,
***P < 0.001, F(2,12)= 41.00, P < 0.0001. Spinal cord, Welch’s ANOVA followed by unpaired t test with Welch’s correction, *P < 0.05, **P < 0.01 W(2,6.824)
= 11.42, P= 0.0067. n= 6 Ctrl, 6 VHL cKO, 3 VHL/Wls cKO. c Representative confocal images of ERG and IB4 in the P8 cerebral cortex of each group of
mice that had been treated with tamoxifen at P1, P2, and P3. d Density (#/mm2) of ERG+ ECs at P8. One-way ANOVA followed by Tukey’s multiple
comparisons, **P < 0.01, ***P < 0.001. F(2,12)= 92.24, P < 0.0001 cortex, F(2,12)= 24.37, P < 0.0001 spinal cord. n= 6 Ctrl, 6 VHL cKO, 3 VHL/Wls cKO.
Data are shown as mean ± s.d. Source data of b, d are provided as a Source Data file.
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RNAs were analyzed by the Nanodrop oneC microvolume UV-Vis Spectro-
photometer (ND-ONEC-W, Thermo Fisher Scientific). cDNA was synthesized by
Qiagen Omniscript RT Kit (205111, Qiagen). The relative mRNA level of indicated
genes was normalized to that of the internal control Hsp90 and calculated by the
equation 2^(Ct(cycle threshold) of Hsp90− Ct of indicated genes). The gene expression levels
in control groups were normalized to 1. RT-qPCR was conducted by QuantiTect
SYBR® Green PCR Kit (204145, QIAGEN) approaches on Agilent MP3005P
thermocycler. The qPCR primers used in the study were listed in Supplementary
Table 3.
Statistical analyses. Quantification was performed by blinded observers. All
measurements were taken from distinct mice and quantitative data are presented as
means ± standard deviation (s.d.). We used scatter dot plots to present the quan-
tification data throughout our manuscript. Each dot (circle, square, or triangle) in
the scatter dot plots represents one mouse or one independent experiment.
Shapiro–Wilk approach was used for testing data normality. F test was used to
compare the equality of variances of two groups whereas Browne–Forsythe test was
used for comparing the equality of variances of three or more groups. The sta-
tistical methods were described in the figure legends and P value was presented in
each graph. For unpaired, two-tailed Student’s t test, t value and degree of freedom
(df) were presented as t(df) in figure legends. Welch’s correction was used for
Student’s t test if the variances of two groups were unequal after Browne–Forsythe
test. For comparisons among three or more groups with equal variances (tested by
Browne–Forsythe approach), ordinary one-way ANOVA was used followed by
Tukey’s multiple comparisons, otherwise Welch’s ANOVA was used followed by
unpaired t test with Welch’s correction. In ordinary ANOVA, the F ratio and DFn
and DFd was presented as F(DFn,DFd) in the figure legends where DFn stands for
degree of freedom numerator and DFd for degree of freedom of denominator. In
Welch’s ANOVA, the Welch’s F ratio, W and DFn and DFd was presented as
W(DFn,DFd) in the figure legends. All data plotting and statistical analyses were
performed using GraphPad Prism version 8.0. P value less than 0.05 was con-
sidered as significant, whereas greater than 0.05 was assigned as not significant (ns).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The source data underlying Figs. 1b, c, e–m, 2a–k, 3b–d, 4c–f, h, j, k, l, 5c–f, 6a–c, f–i,
7a–g, 8c, d, f–g, 9a, b, d, e, g, h, 10b, d, Supplementary Figs. 3b–d, 4c, f, g, 6, 7b, 8a, b, 9b,
c, 10a–d, 11b, 12b, c, e, f, 13b are provided as a Source Data file. The data that support
this study are available from the corresponding author upon reasonable request.
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